MiMedx Enters $25 Million Patent License Agreement to Resolve Infringement Claims
MiMedx Group (MDXG) has reached a settlement with a competitor in the wound care sector through a patent licensing agreement. The deal effectively resolves ongoing allegations regarding the infringement of MiMedx's intellectual property. Under the terms of the agreement, the licensee is required to pay MiMedx a total of $25 million. This payment will be structured in five equal installments, providing a steady stream of non-dilutive capital for the company.
Tickers: $MDXG
Topics: legal settlement licensing agreement patent infringement